Background
==========

Despite therapeutic advances in the treatment of acute myocardial infarction (AMI) over the past two decades, the condition continues to be a leading cause of death in older adults in developed countries. Since the risk of experiencing an AMI increases with age \[[@B1]\], changes in the occurrence of this disorder have a major impact on the overall health of a country\'s population and its healthcare system.

In Canada, the population is aging and the country is particularly impacted by the baby boom generation. Baby boomers constitute almost one-third of the Canadian population, a larger proportion than in the other three countries (Australia, New Zealand and the United States) that experienced the baby boom effect. From 2008 onward, the leading edge of the boomer generation (those born between 1947 and 1966 \[[@B2]\]) moved into their 60s, while its youngest members edged into their 40s. Aging baby boomers have the potential to stretch an already over-extended healthcare system over the next few decades.

In addition to the aging population, there is an unprecedented and growing number of young Canadian adults who are overweight or obese \[[@B3]\], women are entering their adult years with a higher risk for heart disease \[[@B4]\] and some of Canada\'s fastest growing ethno-cultural communities are predisposed to a heavier burden of risk factors for cardiovascular disease \[[@B5],[@B6]\]. All these factors could potentially overwhelm the healthcare system with an entire new generation of patients \[[@B7]\].

The objective of this analysis was to examine trends in the hospitalization rate for AMI in Canada between 2002 and 2009 and to estimate the potential increase in the number of hospitalizations for AMI over the next decade.

Methods
=======

Aggregated data on annual hospitalizations with a most responsible (principal) diagnosis of AMI using International Classification of Diseases (ICD) codes (ICD-9 410 and ICD-10-CA I21 and I22) were obtained from the Discharge Abstract Database and Hospital Morbidity Database of the Canadian Institute for Health Information (CIHI) for nine of Canada\'s 10 provinces and all three of its territories for the fiscal years 2002/03 to 2009/10 inclusive \[[@B8]\]. The CIHI data record hospitalizations only and it is not possible to link hospitalizations for individual patients so that we could not link a re-admission for the same AMI episode or a new AMI with a previous one in the same patient. Information was only available for 2002/03-2009/10 and, since data from Quebec were unavailable for most of the time period, Quebec was excluded from the analysis.

The CIHI data were categorized into 10 age groups starting at \< 45 years (since this is the age at which the risk of an AMI begins to increase) and ending at ≥ 85 years and these were re-grouped into four categories (\< 50, 50-64, 65-74 and ≥ 75 years) for consistency with previous analyses \[[@B1],[@B9],[@B10]\]. Data were also obtained on the two most relevant revascularization procedures (percutaneous coronary intervention \[PCI\] and/or coronary artery bypass graft \[CABG\]) and the length of stay (LOS), categorized as 1-3 days, 4-6 days, 7-11 days or 12 + days by CIHI, associated with each hospitalization. The mean LOS for each gender/age group in each year was estimated using the midpoint of each of the first three categories and 14 days for the final one.

Using provincial and territorial mid-year population estimates obtained from Statistics Canada, annual rates of AMI hospitalization and associated rates of revascularization procedures were estimated for the four age groups stratified by gender. The rates were calculated by dividing the number of hospitalizations for each age-gender category by the corresponding population estimate and age and gender standardized to the 2002 population.

The annual rates of AMI hospitalization for 2002 to 2009 were analyzed using a log-linear Poisson regression model to control for age (four categories), gender and fiscal year (as a continuous variable ranging between zero and seven). The use of four age groups led to a larger number of hospitalization events within each age category and, subsequently, to a more parsimonious and stable model. Two-way interaction terms between age category, gender and fiscal year were also considered in the Poisson model to increase its flexibility. The annual population estimate in each age-gender category (eight in total) was included as an offset term to account for different size of the population at risk. The models were fitted on 64 observed data points (four age groups X two genders X eight years) using a quasi-likelihood approach to account for over-dispersion. The unit of analysis can be considered as person-year assuming all eight age-gender groups were at risk of being hospitalized for AMI throughout a year. An over-dispersion parameter, estimated by dividing the square root of the Pearson *χ*^2^value by the residual degrees of freedom, was introduced to reflect the greater variability in the observed data than expected from the Poisson distribution \[[@B11],[@B12]\]. The model goodness-of-fit was examined using the deviance and Pearson *χ*^2^values. Final model selection was based on change in the Akaike information criterion, a measure of the relative goodness of fit of a statistical model, and the Bayesian information criterion.

The regression model was used to estimate the rate of AMI hospitalizations between 2010 and 2020. Statistics Canada has projected the national and provincial populations to 2036 based on the 2009 population and a series of assumptions which are \"summarized into a few scenarios that are intended to be both plausible and relevant\" so that they \"offer a range of possibilities as to how the Canadian population will evolve in the future\"\[[@B13]\]. The projections are produced by means of a micro-simulation method using a number of variables that reflect the ethno-cultural diversity of the Canadian population, with the basic geographic level being country\'s 33 census metropolitan areas. The projections are intended for a wide range of users including the federal government, provincial, territorial or municipal governments, research groups, academics, interest groups, international and non-governmental organizations, educational institutions and the general public.

The projections are based on six scenarios (Table [1](#T1){ref-type="table"}) that use varying estimates of fertility, life expectancy, immigration and interprovincial migration. The most important of these is the first medium growth scenario (number 2 in Table [1](#T1){ref-type="table"}), which Statistics Canada generally uses in its own analyses. In previous projections, the medium scenario has been found to be close to reality \[[@B13]\]. Using the population projections of scenario 2 and the AMI rate estimates, annual absolute numbers of AMI hospitalizations for the eight age-gender categories between 2010 and 2020 were estimated. Population projections from Statistics Canada\'s low and high scenarios (numbers 1 and 6 in Table [1](#T1){ref-type="table"}) were used as a sensitivity assessment.

###### 

The six scenarios used by Statistics Canada for population projection \[[@B13]\]

  Scenario   Fertility                                         Life expectancy   Immigration   Interprovincial migration   
  ---------- ------------------------------------------------- ----------------- ------------- --------------------------- -------------------------------
  1          Low growth                                        Low               Low           Low                         Historical trends (1981-2008)
  2          Medium growth, historical trends (1981 to 2008)   Medium            Medium        Medium                      Historical trends (1981-2008)
  3          Medium growth, trends 2006 to 2008                Medium            Medium        Medium                      2006 to 2008 trends
  4          Medium growth, trends 1988 to 1996                Medium            Medium        Medium                      1988 to 1996 trends
  5          Medium growth, trends 2001 to 2006                Medium            Medium        Medium                      2001 to 2006 trends
  6          High growth                                       High              High          High                        Historical trends (1981-2008)

Data from CIHI on estimates of the average cost of an AMI without and with a cardiac catheter in Canada \[[@B14]\] were used to estimate the impact of projected changes in the number of AMI hospitalizations.

The data on PCI and CABG were examined to assess what percentage of the hospitalizations included these procedures. Similarly, trends in LOS were reviewed.

Results
=======

The rates of AMI hospitalizations by gender and age group are shown in Figure [1a](#F1){ref-type="fig"} and [1b](#F1){ref-type="fig"}. In general, the rates show a decrease between 2002 and 2009 in the two oldest age groups (65-74 and ≥ 75 years) and a modest increase in the younger age groups (\< 50 and 50-64 years) in both sexes.

![**a Actual and projected rate of AMI hospitalization in Canadian males by age group, 2002-2020**. AMI: Acute myocardial infarction. **b**Actual and projected rate of AMI hospitalization in Canadian females by age group, 2002-2020. AMI: Acute myocardial infarction.](1471-2261-12-25-1){#F1}

The final Poisson regression model contained three main effects (age, gender and year) and three two-way interactions between the main effects (Appendix). This reflected the observed difference in the rate of AMI hospitalization between eight age by gender groups at baseline (year 2002) and allowed year to have different effects on the AMI rate among the groups. Using the Poisson regression model, the projections of the rates between 2010 and 2020 show stable estimates of the rate of AMI hospitalization in males and females aged \< 65 years and decreasing rates in patients aged ≥ 65 years (Figure [1a](#F1){ref-type="fig"} and [1b](#F1){ref-type="fig"}), although the model was a better fit in females than males.

The estimated rates, together with the population projections from Statistics Canada, were used to project the number of AMI hospitalizations in Canada (excluding Quebec) to 2020. Table [2](#T2){ref-type="table"} shows the observed and predicted absolute numbers of AMI hospitalizations for males and females in 2009 and the projected numbers for 2020 for the low, medium and high Statistics Canada scenarios. Under the medium scenario, although AMI hospitalizations in the oldest age group are anticipated to decrease, the total number of AMI hospitalizations in Canada (excluding Quebec) is projected to increase by 4667 from 51847 in 2009 to 56514 in 2020, a 9.0% increase. The projected numbers under the low and high scenarios are 55538 and 57497, respectively, which represent increases of 3691 (7.1%) and 5650 (10.9%).

###### 

Observed and estimated absolute numbers of AMI hospitalizations in 2009 and 2020 for Canada (excluding Quebec)

                         2009    2020 projections for 3 population scenarios\*                                           
  -------- ------------- ------- ----------------------------------------------- ------- ------- ------- ------- ------- -------
  Male     \< 50 years   4739    4541                                            5412    14.2    5639    19.0    5863    23.7
           50-64 years   12600   12053                                           14372   14.1    14528   15.3    14689   16.6
           65-74 years   7413    7073                                            9057    22.2    9167    23.7    9287    25.3
           ≥ 75 years    9444    9182                                            8730    -7.6    8923    -5.5    9133    -3.3
           All ages      34196   32849                                           37571   9.9     38257   11.9    38972   14.0
  Female   \< 50 years   1102    1010                                            1307    18.6    1364    23.8    1421    28.9
           50-64 years   3988    3758                                            4425    11.0    4468    12.0    4511    13.1
           65-74 years   3531    3593                                            4536    28.5    4579    29.7    4618    30.8
           ≥ 75 years    9030    8888                                            7699    -14.7   7846    -13.1   7875    -12.8
           All ages      17651   17249                                           17967   1.8     18257   3.4     18525   5.0
  Total    51847         50098   55538                                           7.1     56514   9.0     57497   10.9    

*AMI*Acute myocardial infarction

\* Using Statistics Canada population projections

† Percentage change over the 2009 observed figure

The estimated mean LOSs between 2002 and 2009 for males and females combined in each age group and each year are shown in Figure [2](#F2){ref-type="fig"}. The genders were combined because there was little difference between them, although the LOS for females was always slightly greater than that for males. The mean LOS declined in each age group by 17-33%, with decreases of 1.8, 2.1, 1.9 and 1.3 days in patients aged \< 50, 50-64, 65-74 and ≥ 75 years, respectively.

![**Estimated mean length of hospital stay for AMI by age group, 2002-2009**. AMI: Acute myocardial infarction.](1471-2261-12-25-2){#F2}

The percentage of AMI hospitalizations with a PCI in Canada (excluding Quebec) increased between 2002 and 2009 in both males and females in each age group (Figure [3a](#F3){ref-type="fig"} and [3b](#F3){ref-type="fig"}). The increase was greatest in patients aged ≥ 75 years (three-fold), compared with approximately a two-fold increase in the other age groups. In contrast, the percentage of AMI hospitalizations with a CABG decreased in the eight-year period by more than half in both males and females from 2.5% and 1.3%, respectively, in 2002 to 0.9% and 0.5% in 2009 (Figure [4a](#F4){ref-type="fig"} and [4b](#F4){ref-type="fig"}).

![**a Percentage of AMI hospitalizations with a PCI in Canadian males by age group, 2002-2009**. AMI: Acute myocardial infarction. PCI: Percutaneous coronary intervention. b Percentage of AMI hospitalizations with a PCI in Canadian females by age group, 2002-2009. AMI: Acute myocardial infarction, PCI: Percutaneous coronary intervention.](1471-2261-12-25-3){#F3}

![**a Percentage of AMI hospitalizations with a CABG in Canadian males by age group, 2002-2009**. AMI: Acute myocardial infarction. CABG: Coronary artery bypass graft. **b**Percentage of AMI hospitalizations with a CABG in Canadian females by age group, 2002-2009. AMI: Acute myocardial infarction. CABG: Coronary artery bypass graft.](1471-2261-12-25-4){#F4}

Discussion
==========

Hospital discharge abstract databases are increasingly being used in health services research. AMI diagnostic codes in Canadian administrative databases have been validated using the hospital discharge data and chart audits \[[@B15]-[@B18]\]. For example, Austin *et al.*found a sensitivity of 89% and a specificity of 93% for patients admitted to coronary care units \[[@B17]\]. Administrative data have been used in surveillance of cardiovascular surveillance \[[@B1],[@B9],[@B10],[@B19]-[@B21]\] and other conditions \[[@B22]\] with success.

The decreasing hospitalization rate for AMI in Canada has been described by others previously. In particular, in 2009, Tu and his colleagues reported a substantial decrease in hospitalization rates (standardized to the 1991 population) for AMI and other cardiovascular disorders from 1994 to 2004 using CIHI data for the whole of Canada \[[@B1]\]. Our study resulted in a rate for 2004 are quite similar to that of Tu *et al.*, despite not having data for Quebec.

Similarly, the increasing use of PCI and the declining use of CABG in AMI patients have also been previously reported. Ko *et al.*showed that, between 2001-03 and 2004-06, the rate of PCI use per 100,000 population in Ontario rose by 20%, while the rate of CABG use fell by 10% \[[@B23]\]. In the CIHI data, the rate of PCI in Canada (excluding Quebec) increased between 2002 and 2009 by 125% and the rate of CABG declined by over 60%. Thus, there has been a significant change in the type of care (PCI v. CABG) over recent years in Canada with PCI, which has been described as having a direct impact on patient survival. PCI remains a central therapy for patients with symptomatic coronary artery disease, particularly those with AMI, and has generated tremendous attention in the last decade with issues such as the risks and benefits of drug-eluting stents and anti-thrombotic therapies \[[@B24]\]. There are few representative data describing the contemporary patterns of care and outcome trends in patient with AMI and/or undergoing PCI. This is of particular importance because the process of updating clinical practice guidelines and quality metrics for AMI and PCI has accelerated.

The present analysis extends the previous work of Tu *et al.*\[[@B1]\] to a more recent year (2009) and attempts to project not only the rates, which our analysis suggests will continue to decline in those aged ≥ 65 years and remain relatively stable in those aged \< 65 years, but also the numbers of AMI hospitalizations to 2020. Despite projected decreasing or stable rates of AMI hospitalization, the number of hospitalizations is expected to increase substantially as a result of the aging of the Canadian population.

Our model indicates an increase in Canada (excluding Quebec) of 4667 AMI hospitalizations by 2020, with a sensitivity range of 3691 to 5650. Quebec represents approximately 25% of the Canadian population, which suggests an increase of about 6200 for the whole of Canada (sensitivity range, 4900 to 7500). Using the CIHI estimate for the average cost of a myocardial infarction/shock/arrest without cardiac catheter in Canada in 2008/09 of \$7412 \[[@B14]\], the additional cost for this increase in AMI hospitalizations would be approximately \$46 million (sensitivity range, \$36-\$55 million). If one assumes that the majority of AMI hospitalizations (80%) will include a cardiac catheter for which the average cost in Canada in 2008/09 was \$8984 \[[@B14]\], the additional cost for the projected increase in the number of AMI hospitalizations to 2020 would be approximately \$54 million (sensitivity range, \$42-\$65 million). These figures do not take account of economic inflation, changes in AMI risk due to the epidemic in diabetes and obesity, or the fact that seniors generally have a longer LOS.

Attempting to incorporate changes in the use of PCI or CABG and in LOS with the projected trend in AMI hospitalizations was problematic. If one extrapolates the linear increase in the proportion of AMI hospitalizations with a PCI between 2002 and 2009, by 2020 almost all AMI hospitalizations would have a PCI. Projecting the proportion of AMI hospitalizations with a CABG would suggest that almost no AMI hospitalizations in 2020 would have a CABG. These scenarios are unrealistic. While the proportion of AMI hospitalizations with a PCI are likely to continue to increase and the proportion with a CABG may continue to decrease, it is anticipated that they will plateau at some point, but our data do not allow us to estimate where this could be expected to occur, although it seems likely that it will be before 2020. Similarly, the trend of shortening average LOS may continue for some years but eventually a minimum must be reached. Thus, we have not provided projections for these variables.

Our analysis has limitations. The CIHI data record only hospitalizations and not individual episodes of patient care and it was not possible to include Quebec in the analysis. The coding of hospitalizations changed from ICD-9 to ICD-10 between 2001/02 and 2002/03 in most provinces and territories but did not occur until 2003/04 in New Brunswick and 2004/05 in Manitoba. The change in coding system included a reduction in the eight-week period after an initial AMI hospitalization in which readmission for AMI-related problems would be counted as continuing care in ICD-9 to four weeks in ICD-10. This change in coding does not explain the decrease in 2006; we are unable to ascertain a reason for this reduction, but it should be noted that, if data from only 2002/03 to 2006/07 had been used, the results of the projection in numbers of AMI hospitalizations would likely have been quite different. We considered it appropriate to use all the data available rather than selectively use them. Fiscal year was used as a linear variable, which is a traditional approach, because it was considered to be the most reliable based on the limited number of years available and the structure of the data (Figures [1a](#F1){ref-type="fig"} and [1b](#F1){ref-type="fig"}).

As previously mentioned, the projection in AMI hospitalization rates did not take account of the increasing prevalence of diabetes and obesity in the Canadian population (especially in young adults) or changes in cardiovascular drug therapy, such as increasing use of statins and anti-hypertensives. It also assumed that the treatment of cardiovascular disease and AMI in particular will remain largely the same over the next 10 years, although new clinical practices, in which physicians are able to predict the prognosis for an AMI patient with greater accuracy, could emerge that would lead to a reduction in the likelihood of hospitalization for AMI or the length of stay \[[@B25]-[@B27]\]. These limitations point to the need for a more comprehensive and refined national disease surveillance system in Canada with which more in depth studies would be performed.

Conclusions
===========

Despite continued efforts to prevent cardiovascular disease, which as evidenced by the declining rate of AMI hospitalization in older Canadians, cardiovascular disease continues to be the leading cause of death and reason for hospital admissions. Moreover, there is little indication of a radical change in cardiovascular therapy that will substantially reduce the risk of AMI, whereas it is clear that the Canadian population is aging and the prevalence of diabetes and obesity is increasing, which will significantly impact the already over-stretched Canadian healthcare system. Further advances in the prevention and treatment of cardiovascular disease are required, together with an improved nationwide surveillance system of cardiovascular events. To more completely assess the burden of heart disease, it is important not only to determine how many people are hospitalized as a result of it or die from it, but also to monitor how many live with heart disease and its impact on their quality of life.
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Appendix
========

A.1. Final Poisson regression model
-----------------------------------

Log (count/population) = β~0~+ β~1~\*Year + β~2~\*I(≥ 75 years) + β~3~\*I(65-74 years) + β~4~\*I(50-64 years) + β~5~\*Female + β~6~\*I(Female, ≥ 75 years) + β~7~\*I(Female, 65-74 years) + β~8~\*I(Female, 50-64 years) + β~9~\*Year\*Female + β~10~\*Year\*I(≥ 75 years) + β~11~\*Year\*I(65-74 years) + β~12~\*Year\* I(50-64 years), where Year = 0,\...,7

Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}

###### 

Parameter estimates in the Poisson model

  Parameter                    Estimate (standard error)   95% Confidence interval   P-value
  ---------------------------- --------------------------- ------------------------- ---------
  ≥ 75 years (β~2~)            3.61(0.07)                  3.48, 3.73                \< 0.01
  65-74 years (β~3~)           2.98 (0.07)                 2.85, 3.12                \< 0.01
  50-64 years (β~4~)           2.34 (0.07)                 2.21, 2.47                \< 0.01
  Female (β~5~)                -1.39 (0.08)                -1.54, -1.23              \< 0.01
  Female, ≥ 75 years (β~6~)    0.98 (0.08)                 0.82, 1.13                \< 0.01
  Female, 65-74 years (β~7~)   0.63 (0.08)                 0.46, 0.80                \< 0.01
  Female, 50-64 years (β~8~)   0.21 (0.08)                 0.04, 0.37                0.01
  Year (β~1~)                  0.01 (0.01)                 -0.01, 0.04               0.24
  Year\*Female (β~9~)          -0.0005 (0.01)              -0.02, 0.02               0.95
  Year\* ≥ 75+ years (β~10~)   -0.05 (0.01)                -0.08, -0.02              \< 0.01
  Year\*65-74 years (β~11~)    -0.04 (0.02)                -0.07, 0.00               0.02
  Year\*50-64 years (β~12~)    -0.01 (0.01)                -0.04, 0.02               0.34
  Scale^†^                     5.96                                                  

Deviance = 1842.83, Pearson *χ*^2^= 1810.59, degrees of freedom = 51, Akaike information criterion = 96.53, Bayesian information criterion = 124.60

^†^Scale parameter estimated by square root of Pearson\'s *χ*^2^/degrees of freedom

###### 

Estimated baseline log rates (year 2002) and time effects for eight groups

  Gender\*Age group     Log (rate of hospitalization)   Intercept                Slope for fiscal year
  --------------------- ------------------------------- ------------------------ ----------------------------
  Male, ≥ 75 years      Log (count/population) =        β~0~+ β~2~               β~1~+ β~10~(-0.0329)
                                                                                 
  Male, 65-74 years                                     β~0~+ β~3~               β~1~+ β~11~(-0.0203)
                                                                                 
  Male, 50-64 years                                     β~0~+ β~4~               β~1~+ β~12~(0.0008)
                                                                                 
  Male, \< 50 years                                     β~0~                     β~1~(0.0149)
                                                                                 
  Female, ≥ 75 years                                    β~0~+ β~5~+ β~2~+ β~6~   β~1~+ β~9~+ β~10~(-0.0334)
                                                                                 
  Female, 65-74 years                                   β~0~+ β~5~+ β~3~+ β~7~   β~1~+ β~9~+ β~11~(-0.0208)
                                                                                 
  Female, 50-64 years                                   β~0~+ β~5~+ β~4~+ β~8~   β~1~+ β~9~+ β~12~(0.0003)
                                                                                 
  Female, \< 50 years                                   β~0~+ β~5~               β~1~+ β~9~(0.0144)

Pre-publication history
=======================

The pre-publication history for this paper can be accessed here:

<http://www.biomedcentral.com/1471-2261/12/25/prepub>

Acknowledgements
================

We thank the staff of the Canadian Institute for Health Information for extracting and providing the data for this analysis. The views expressed are those of the authors and do not necessarily represent those of GlaxoSmithKline, the Canadian Institute for Health Information, or any other organization. Funding for the data purchase was provided by GlaxoSmithKline.
